StockData
20/20 Biolabs, Inc. logo

20/20 Biolabs, Inc. (AIDX) bonds

AIDXNasdaqServices-Testing LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3069% below fair value
$0.18−0.02 (-9.45%)

Close on Nov 16, 2026Market cap $2.36MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

20/20 Biolabs reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in 20/20 Biolabs's 10-Q for the period ended Mar 31, 2026

IssueAmount issuedCarrying value
Convertible Promissory Notes Equity Crowdfunding
Convertible
$712.26K$561.17K
Convertible Promissory Notes Prior Equity Crowdfunding
Convertible
$306.72K$213.01K
Convertible Promissory Notes Private Placement
Convertible
$70.00K$70.00K

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?